By Karen Roman Candel Therapeutics, Inc. (Nasdaq: CADL) said Phase 3 of its prostate cancer candidate CAN-2409 showed an upgrade in disease-free survival in intermediate-to-high-risk patients. “We ...
They rarely listen, they’re full of their own problems and often imply that you’re not quite good enough ...
Cllr Sean McGowan urged the HSE to detail south Leitrim services and stressed the need to fill local vacancies at meeting of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback